Table 3 Body composition measurements during the dietary intervention measured using DEXA. Data is presented as mean ± SEM
Week 0 | Week 16 | q-value (β coefficients) | |||
|---|---|---|---|---|---|
Time | Treatment | Interaction | |||
Total fat mass (kg) | |||||
CG | 22.03 ± 0.62 | 20.64 ± 0.64 | 2.48×10-5 (-0.008) | 0.40 (0.19) | 0.45 (-0.004) |
IG | 22.06 ± 0.68 | 20.61 ± 0.68 | |||
Visceral fat mass (g) | |||||
CG | 645.92 ± 31.38 | 582.61 ± 29.52 | 0.1 (0.001) | 0.99 (0.001) | 0.86 (-0.0006) |
IG | 624.41 ± 27.55 | 557.27 ± 26.68 | |||
Android fat mass (kg) | |||||
CG | 2.12 ± 0.07 | 1.91 ± 0.07 | 3.10×10-6 (-0.007) | 0.72 (-0.1) | 0.87 (-0.002) |
IG | 2.05 ± 0.08 | 1.84 ± 0.08 | |||
Gynoid fat mass (kg) | |||||
CG | 3.61 ± 0.12 | 3.38 ± 0.12 | 0.02 (-0.004) | 0.72 (0.08) | 0.86 (-0.002) |
IG | 3.59 ± 0.12 | 3.31 ± 0.12 | |||
Android to gynoid fat ratio | |||||
CG | 1.13 ± 0.02 | 1.10 ± 0.02 | 1.59×10-10 (-0.02) | 0.72 (-0.21) | 0.87 (-0.001) |
IG | 1.11 ± 0.02 | 1.10 ± 0.03 | |||
Total lean mass (kg) | |||||
CG | 40.28 ± 1.07 | 39.45 ± 1.09 | 5.37×10-11 (-0.007) | 0.40 (0.17) | 0.31 (-0.003) |
IG | 41.45 ± 1.09 | 40.21 ± 1.09 | |||
Total lean mass/total fat mass ratio | |||||
CG | 1.94 ± 0.09 | 2.05 ± 0.010 | 1.28×10-16 (−0.02) | 0.99 (0.001) | 0.87 (−0.002) |
IG | 2.03 ± 0.10 | 2.11 ± 0.11 | |||